| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Trial |
We wanted to compare the efficacy and safety of fluticasone propionate, a new topically active inhaled corticosteroid, to that of high dose beclomethasone dipropionate, in severe adult asthma. Patients currently receiving between 1.5-2.0 mg.day-1 of an inhaled corticosteroid were treated for six weeks in a double-blind, randomized, parallel group study with 1 mg.day-1 fluticasone propionate (n = 82), or 2 mg.day-1 beclomethasone dipropionate (n = 72). Mean morning peak expiratory flow rates (PEFR) increased from 303 to 321 l.min-1 with fluticasone propionate, and from 294 to 319 l.min-1 with beclomethasone dipropionate. There was an increase in evening PEFR, asthma symptoms improved, and rescue beta 2-agonist use decreased for both treatment groups. None of these differences between treatments were statistically significant. However, diurnal variation was significantly reduced with fluticasone propionate, when compared with beclomethasone dipropionate (difference = 7 l.min-1; p = 0.038). Clinic lung function also improved with both treatments and, apart from % predicted PEFR, which showed no difference after beclomethasone dipropionate but increased from 73 to 78% with fluticasone propionate, there were no differences between treatments. Forced expiratory volume in one second (FEV1) increased with both treatments. The geometric mean plasma cortisol concentration rose after treatment with fluticasone propionate (from 293 to 309 nmol.l-1) and fell after beclomethasone dipropionate (from 256 to 224 nmol.l-1); the difference between treatments was significant. The incidence of adverse events was low in both treatment groups. In conclusion, 1 mg.day-1 fluticasone propionate was as effective as 2 mg.day-1 beclomethasone dipropionate in the control of severe asthma.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  S. Schuh, P. T. Dick, D. Stephens, M. Hartley, S. Khaikin, L. Rodrigues, and A. L. Coates High-Dose Inhaled Fluticasone Does Not Replace Oral Prednisolone in Children With Mild to Moderate Acute Asthma Pediatrics, August 1, 2006; 118(2): 644 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Murphy, P. Gibson, P. I. Talbot, and V. L. Clifton Severe Asthma Exacerbations During Pregnancy Obstet. Gynecol., November 1, 2005; 106(5): 1046 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Murphy, P. G. Gibson, R. Smith, and V. L. Clifton Asthma during pregnancy: mechanisms and treatment implications Eur. Respir. J., April 1, 2005; 25(4): 731 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Murphy, P. G. Gibson, W. B. Giles, T. Zakar, R. Smith, A. M. Bisits, C. G. Kessell, and V. L. Clifton Maternal Asthma Is Associated with Reduced Female Fetal Growth Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1317 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Lynd, D. P. Guh, P. D. Pare, and A. H. Anis Patterns of Inhaled Asthma Medication Use: A 3-Year Longitudinal Analysis of Prescription Claims Data From British Columbia, Canada Chest, December 1, 2002; 122(6): 1973 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. de Benedictis, A. Teper, R. J. Green, A. L. Boner, L. Williams, H. Medley, and for the International Study Group Effects of 2 Inhaled Corticosteroids on Growth: Results of a Randomized Controlled Trial Arch Pediatr Adolesc Med, November 1, 2001; 155(11): 1248 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Holt, A. Suder, M. Weatherall, S. Cheng, P. Shirtcliffe, R. Beasley, and A. Herxheimer Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis Commentary: Dosage needs systematic and critical review BMJ, August 4, 2001; 323(7307): 253 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Gibson, J. L. Simpson, and N. Saltos Heterogeneity of Airway Inflammation in Persistent Asthma : Evidence of Neutrophilic Inflammation and Increased Sputum Interleukin-8 Chest, May 1, 2001; 119(5): 1329 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T W Harrison, A Wisniewski, J Honour, and A E Tattersfield Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects Thorax, March 1, 2001; 56(3): 186 - 191. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Schuh, J. Reisman, M. Alshehri, A. Dupuis, M. Corey, R. Arseneault, G. Alothman, O. Tennis, and G. Canny A Comparison of Inhaled Fluticasone and Oral Prednisone for Children with Severe Acute Asthma N. Engl. J. Med., September 7, 2000; 343(10): 689 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. ZuWallack, J. Adelglass, D. P. Clifford, S. P. Duke, P. D. Wire, M. Faris, and S. M. Harding Long-term Efficacy and Safety of Fluticasone Propionate Powder Administered Once or Twice Daily via Inhaler to Patients With Moderate Asthma Chest, August 1, 2000; 118(2): 303 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T C Medici, E Grebski, M Häcki, P Rüegsegger, C Maden, and J Efthimiou Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects Thorax, May 1, 2000; 55(5): 375 - 382. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. J. Lipworth Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis Arch Intern Med, May 10, 1999; 159(9): 941 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wales, H. Makker, J. Kane, P. McDowell, and B. R. O'Driscoll Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids: A Comparison of Four Inhaler Devices and Three Drugs in Healthy Adult Volunteers Chest, May 1, 1999; 115(5): 1278 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. T. NOCKER, F. R. WELLER, T. A. OUT, M. J. de RIEMER, H. M. JANSEN, and J. S. van der ZEE A Double-blind Study on the Effect of Inhaled Corticosteroids on Plasma Protein Exudation in Asthma Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1499 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T F Fok, K Lam, M Dolovich, P C Ng, W Wong, K L Cheung, and K W So Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1999; 80(3): 203F - 208. [Abstract] [Full Text]
|
|
|
|
|
|
A. M Wilson and B. J Lipworth 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids Thorax, January 1, 1999; 54(1): 20 - 26. [Abstract] [Full Text]
|
|
|
|
|
|
D. Fitzgerald, P. Van Asperen, C. Mellis, M. Honner, L. Smith, and G. Ambler Fluticasone propionate 750 µg/day versus beclomethasone dipropionate 1500 µg/day: comparison of efficacy and adrenal function in paediatric asthma Thorax, August 1, 1998; 53(8): 656 - 661. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. C. Ng, T. F. Fok, G. W. K. Wong, C. W. K. Lam, C. H. Lee, M. Y. Wong, K. Lam, and K. C. Ma Pituitary-Adrenal Suppression in Preterm, Very Low Birth Weight Infants after Inhaled Fluticasone Propionate Treatment J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2390 - 2393. [Abstract] [Full Text]
|
|
|
|
|
|
P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]
|
|
|
|
|
|
R. A. PAUWELS, J. C. YERNAULT, M. G. DEMEDTS, and P. GEUSENS Safety and Efficacy of Fluticasone and Beclomethasone in Moderate to Severe Asthma Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 827 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Donnelly, K. Williams, A. Baker, C. Badcock, R. Day, and J. Seale Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1746 - 1751. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. K Yiallouros, A. D Milner, E. Conway, and J. W Honour Adrenal function and high dose inhaled corticosteroids for asthma Arch. Dis. Child., May 1, 1997; 76(5): 405 - 410. [Abstract] [Full Text]
|
|
|
|
|
|
North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of asthma in adults BMJ, March 23, 1996; 312(7033): 762 - 766. [Full Text]
|
|
|
|
 |
|
 {blacktriangledown}Fluticasone propionate for asthma prophylaxis DTB, April 1, 1994; 32(4): 25 - 27. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
